Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M746Revenue $M2.8Net Margin (%)-280.9Z-Score-0.3
Enterprise Value $M711EPS $-2.8Operating Margin %-188.1F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-281.5Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsN
Price/Sales19.05-y EBITDA Growth Rate %0Current Ratio0.9Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-294.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.3ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CHRS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEALY JAMESDirector 2014-11-12Buy425,926$13.5134view
LILLY ELI & CO 2014-11-12Buy164,963$13.5134view
Herman Alan C.Chief Scientific Officer 2014-11-06Sell0$0134view
Lanfear Dennis MSee Remarks 2014-11-06Sell0$0134view
Troendle August J.Director 2014-11-06Sell0$0134view
HEALY JAMESDirector 2014-11-06Sell0$0134view
Ascena Retail Group, Inc.10% Owner 2012-06-14Sell0$0134view
COOPERMAN LEON G10% Owner 2012-03-28Buy432,600$5.6464.11view
COOPERMAN LEON G10% Owner 2012-02-22Buy291,900$5.21506.33view
GOLDSTEIN MICHAELDirector 2010-10-15Buy10,000$3.51800view

Press Releases about CHRS :

    Quarterly/Annual Reports about CHRS:

      News about CHRS:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2 Feb 23 2015
      Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2 Feb 23 2015
      Lane Bryant sales up, but CEO says it can do better Feb 18 2015
      Coherus Biosciences (CHRS) Jumps: Stock Moves Up 12.7% - Tale of the Tape Feb 06 2015
      Coherus BioSciences to Present at Leerink Healthcare Conference on February 11 Feb 04 2015
      How to Invest in the New Industry of 'Biosimilar' or 'Generic' Biological Drugs Jan 09 2015
      Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results Dec 15 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Dec 15 2014
      Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results Dec 15 2014
      Q3 2014 Coherus Biosciences Inc Earnings Release - After Market Close Dec 15 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 11 2014
      Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12 Dec 08 2014
      Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12 Dec 08 2014
      KKR to Acquire Minority Stake in Arbor Pharmaceuticals Dec 05 2014
      Coherus BioSciences to Host Earnings Conference Call on December 15 Dec 04 2014
      Coherus BioSciences to Host Earnings Conference Call on December 15 Dec 04 2014
      Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock Nov 19 2014
      Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters'... Nov 19 2014
      COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Nov 13 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK